| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |